Moody National Bank Trust Division Exact Sciences Corp Transaction History

Moody National Bank Trust Division

$922 Million
Q3 2024

A detailed history of Moody National Bank Trust Division transactions in Exact Sciences Corp stock. As of the latest transaction made, Moody National Bank Trust Division holds 11,764 shares of EXAS stock, worth $676,194. This represents 0.09% of its overall portfolio holdings.

Number of Shares

11,764

Previous 9,573 22.89%

Holding current value

$676,194

Previous $404,000 98.27%

% of portfolio

0.09%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$42.43 - $70.83 $92,964 - $155,188	2,191 Added 22.89%	11,764 $801,000
Q2 2024 Jul 03, 2024	BUY	$41.33 - $74.26 $30,625 - $55,026	741 Added 8.39%	9,573 $404,000
Q1 2024 Apr 04, 2024	BUY	$56.27 - $73.77 $6,077 - $7,967	108 Added 1.24%	8,832 $609,000
Q4 2023 Jan 11, 2024	SELL	$59.06 - $75.72 $79,967 - $102,524	-1,354 Reduced 13.44%	8,724 $645,000
Q3 2023 Oct 12, 2023	BUY	$65.94 - $99.04 $132,935 - $199,664	2,016 Added 25.01%	10,078 $687,000
Q2 2023 Jul 07, 2023	BUY	$62.68 - $95.05 $14,917 - $22,621	238 Added 3.04%	8,062 $757,000
Q4 2022 Jan 11, 2023	BUY	$30.35 - $53.15 $7,405 - $12,968	244 Added 3.22%	7,824 $387,000
Q2 2022 Jul 07, 2022	SELL	$35.61 - $76.23 $398,832 - $853,776	-11,200 Reduced 59.64%	7,580 $299,000
Q1 2022 Apr 12, 2022	SELL	$57.56 - $82.54 $165,024 - $236,642	-2,867 Reduced 13.24%	18,780 $1.31 Million
Q4 2021 Jan 13, 2022	SELL	$72.5 - $100.68 $5.52 Million - $7.67 Million	-76,195 Reduced 77.88%	21,647 $1.69 Million
Q3 2021 Oct 07, 2021	SELL	$90.24 - $124.05 $8,843 - $12,156	-98 Reduced 0.1%	97,842 $9.34 Million
Q2 2021 Jul 13, 2021	SELL	$93.66 - $139.27 $14,985 - $22,283	-160 Reduced 0.16%	97,940 $12.2 Million
Q1 2021 Apr 14, 2021	SELL	$116.57 - $155.01 $15,736 - $20,926	-135 Reduced 0.14%	98,100 $12.9 Million
Q4 2020 Mar 04, 2021	SELL	$99.61 - $142.12 $2.91 Million - $4.15 Million	-29,215 Reduced 22.92%	98,235 $13 Million
Q1 2020 Apr 17, 2020	SELL	$37.9 - $104.44 $1,895 - $5,222	-50 Reduced 0.04%	127,450 $7.39 Million
Q4 2019 Jan 28, 2020	SELL	$77.66 - $99.74 $5,436 - $6,981	-70 Reduced 0.05%	127,500 $11.8 Million
Q2 2019 Jul 22, 2019	SELL	$89.51 - $118.04 $3.52 Million - $4.65 Million	-39,375 Reduced 23.59%	127,570 $15.1 Million
Q1 2019 Apr 11, 2019	SELL	$61.98 - $96.5 $4,648 - $7,237	-75 Reduced 0.04%	166,945 $14.5 Million
Q3 2018 Oct 31, 2018	BUY	$48.29 - $80.6 $7.41 Million - $12.4 Million	153,370 Added 1123.59%	167,020 $13.2 Million
Q2 2018 Aug 03, 2018	SELL	$37.84 - $69.96 $3,784 - $6,995	-100 Reduced 0.73%	13,650 $816,000
Q1 2018 Apr 16, 2018	SELL	$39.82 - $57.53 $21,901 - $31,641	-550 Reduced 3.85%	13,750 $555,000
Q3 2017 Oct 12, 2017	BUY	$37.05 - $47.12 $529,815 - $673,816	14,300	14,300 $674,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Moody National Bank Trust Division with notifications on news.

Account

Moody National Bank Trust Division Exact Sciences Corp Transaction History